Integra Health

integrahealth.com

Integra Health is a health consultancy and think tank operating out of Lagos, Nigeria with a backbone of 11 consultants and 39 full-time healthcare professionals. We work on profitable innovations and solutions that add sustainable value to developing health systems.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

HEALTH TECHNOLOGY

HEALTHVERITY LAUNCHES CLOUD PLATFORM OFFERING FLEXIBLE TECHNOLOGIES EMPOWERING HEALTHCARE ENTERPRISES

HealthVerity | November 17, 2020

news image

HealthVerity, the pioneer in security ensured data exchange, today reported the business accessibility of its incorporated cloud stage offering adaptable advancements that enable medical care endeavors to plan and assemble their own one of a kind data technique, data work process or data universe, all in a security ensured way. Upheld by an amazing API (application programming interface) suite, HealthVerity customers ca...

Read More

FUTURE OF HEALTHCARE

CLAREMEDICA HEALTH PARTNERS, A LEADING PROVIDER OF VALUE-BASED PRIMARY CARE, RECEIVES INVESTMENT FROM REVELSTOKE CAPITAL PARTNERS

Revelstoke | February 25, 2022

news image

Revelstoke Capital Partners ("Revelstoke"), aDenver-based private equity firm focused on investing in healthcare services companies, today announced it has made a significant growth investment in ClareMedica Health Partners, LLC ("ClareMedica" or the "Company"), a leader in value-based primary care serving Medicare Advantage members inFlorida. This partnership will accelerate ClareMedica's growth and aid the Company in expanding itsBette...

Read More

HEALTH TECHNOLOGY

ANTENGENE ANNOUNCES ATG-101 GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA

Antengene Corporation Limited | September 19, 2022

news image

Antengene Corporation Limited a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. This ODD will help Antenge...

Read More

AWS INITIATIVE TO ACCELERATE COVID-19 DIAGNOSTICS, RESEARCH

Healthcare IT News | March 23, 2020

news image

Amazon joins a growing list of global technology giants stepping up to help battle the global COVID-19 pandemic through the AWS Diagnostic Development Initiative, which aims to accelerate COVID-19 diagnostics, research, and testing. The program, which is backed by an initial investment of $20 million, is open to accredited research institutions and private entities using AWS to support research-oriented workloads for the development of point-of-care diagnostics. This type of diagnostic treatment...

Read More
news image

HEALTH TECHNOLOGY

HEALTHVERITY LAUNCHES CLOUD PLATFORM OFFERING FLEXIBLE TECHNOLOGIES EMPOWERING HEALTHCARE ENTERPRISES

HealthVerity | November 17, 2020

HealthVerity, the pioneer in security ensured data exchange, today reported the business accessibility of its incorporated cloud stage offering adaptable advancements that enable medical care endeavors to plan and assemble their own one of a kind data technique, data work process or data universe, all in a security ensured way. Upheld by an amazing API (application programming interface) suite, HealthVerity customers ca...

Read More
news image

FUTURE OF HEALTHCARE

CLAREMEDICA HEALTH PARTNERS, A LEADING PROVIDER OF VALUE-BASED PRIMARY CARE, RECEIVES INVESTMENT FROM REVELSTOKE CAPITAL PARTNERS

Revelstoke | February 25, 2022

Revelstoke Capital Partners ("Revelstoke"), aDenver-based private equity firm focused on investing in healthcare services companies, today announced it has made a significant growth investment in ClareMedica Health Partners, LLC ("ClareMedica" or the "Company"), a leader in value-based primary care serving Medicare Advantage members inFlorida. This partnership will accelerate ClareMedica's growth and aid the Company in expanding itsBette...

Read More
news image

HEALTH TECHNOLOGY

ANTENGENE ANNOUNCES ATG-101 GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA

Antengene Corporation Limited | September 19, 2022

Antengene Corporation Limited a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. This ODD will help Antenge...

Read More
news image

AWS INITIATIVE TO ACCELERATE COVID-19 DIAGNOSTICS, RESEARCH

Healthcare IT News | March 23, 2020

Amazon joins a growing list of global technology giants stepping up to help battle the global COVID-19 pandemic through the AWS Diagnostic Development Initiative, which aims to accelerate COVID-19 diagnostics, research, and testing. The program, which is backed by an initial investment of $20 million, is open to accredited research institutions and private entities using AWS to support research-oriented workloads for the development of point-of-care diagnostics. This type of diagnostic treatment...

Read More